We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00409045
Recruitment Status : Completed
First Posted : December 8, 2006
Last Update Posted : November 5, 2007
Sponsor:
Information provided by:

Study Description
Brief Summary:
we evaluate the presence of OSA in patients that have a computed tomography (CT) of the chest to rule out pulmonary embolism (PE) to determine if OSA constitutes an independent risk factor for PE.

Condition or disease Phase
Obstructive Sleep Apnea Pulmonary Embolism Phase 1 Phase 2

Study Design

Study Type : Observational
Estimated Enrollment : 300 participants
Time Perspective: Prospective
Official Title: Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism
Study Start Date : November 2005
Study Completion Date : September 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
male and female patients age 18 years and older
Criteria

Inclusion Criteria:

  • male and female patients age 18 years and older with suspected PE
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00409045


Locations
United States, New Jersey
Morristown Memorial Hospital
Morristown, New Jersey, United States, 07962
Sponsors and Collaborators
Atlantic Health System
Investigators
Principal Investigator: Matthew Epstein, MD Atlantic Health System - Morristown Memorial Hospital
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00409045     History of Changes
Other Study ID Numbers: R05-08-002
Sleep Apnea
First Posted: December 8, 2006    Key Record Dates
Last Update Posted: November 5, 2007
Last Verified: October 2007

Keywords provided by Atlantic Health System:
Obstructive Sleep Apnea
Pulmonary Embolism
male and female patients suspected of having a pulmonary embolism.

Additional relevant MeSH terms:
Apnea
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Embolism
Pulmonary Embolism
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Lung Diseases